Bengaluru, Aug. 28 -- During Thursday's trading session, shares of a diversified and integrated pharmaceutical company specialising in API and intermediates surged nearly 10.5 percent on BSE, after receiving an Establishment Inspection Report (EIR) for central laboratory analytical services.

At 10:33 a.m., the shares of SMS Pharmaceuticals Limited were trading in the green at Rs. 244.95 on BSE, up by nearly 6 percent, as against its previous closing price of Rs. 231.25, with a market cap of Rs. 2,171.5 crores. The stock has delivered negative returns of over 28 percent in the last one year, but has gained by about 2 percent in the last one month.

What's the News

According to the latest regulatory filings on the stock exchanges, SMS Pha...